COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00606879
Recruitment Status : Terminated
First Posted : February 5, 2008
Last Update Posted : July 24, 2008
Information provided by:
SGX Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Estimated Primary Completion Date : January 2009
Estimated Study Completion Date : June 2009